The Powerful Influence of Microvascular Obstruction (MVO) in Cardiovascular Clinical Trials

Dr. Jay Traverse is a senior consulting cardiologist at Allina Health Minneapolis Heart Institute and the director of research at MHIF. His special interests include interventional cardiology, stem cell therapy, biomaterials, and ischemia/reperfusion injury. He is also an associate professor of medicine at the University of Minnesota School of Medicine.